WINDLAS BIOTECH
Back to Balance Sheet
|
WINDLAS BIOTECH Last 5 Year Capital Work in Progress History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Capital Work in Progress | ₹56 Cr | ₹3.20 Cr | ₹5.71 Cr | ₹14 Cr | ₹7.58 Cr |
What is the latest Capital Work in Progress ratio of WINDLAS BIOTECH ?
| Year | Capital Work in Progress |
|---|---|
| Mar2026 | ₹56 Cr |
| Mar2025 | ₹3.20 Cr |
| Mar2024 | ₹5.71 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹7.58 Cr |
How is Capital Work in Progress of WINDLAS BIOTECH Trending?
| Years | Capital Work in Progress | % Change | |
|---|---|---|---|
| Mar2026 | ₹56 Cr | 1,654.30 | |
| Mar2025 | ₹3.20 Cr | -43.92 | |
| Mar2024 | ₹5.71 Cr | -58.64 | |
| Mar2023 | ₹14 Cr | 82.05 | |
| Mar2022 | ₹7.58 Cr | - | |
Compare Capital Work in Progress of peers of WINDLAS BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WINDLAS BIOTECH | ₹2,322.8 Cr | 1.4% | 21.3% | 16.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹447,236.0 Cr | -1.9% | -3.7% | 18.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹249,673.0 Cr | 2.6% | 11.1% | 56% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,460.0 Cr | 0.2% | 1.3% | 38% | Stock Analytics | |
| CIPLA | ₹111,484.0 Cr | -1.5% | -6.4% | -12.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,220.3 Cr | -1% | -5.1% | -8.1% | Stock Analytics | |
WINDLAS BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WINDLAS BIOTECH | 1.4% |
21.3% |
16.8% |
| SENSEX | -1.6% |
-4.2% |
-7.2% |
You may also like the below Video Courses